Peripheral Arterial Disease and Risk of Atrial Fibrillation and Stroke: The Multi−Ethnic Study of Atherosclerosis
Is the presence of peripheral artery disease (PAD) associated with an increased risk of atrial fibrillation (AF) and a subsequent risk of stroke?
Stroke Prevention in Atrial Fibrillation: Advancements in LAA Closure and Novel Oral Anticoagulation Therapy – Webcast on Demand
The webcast is comprised of the proceedings from the satellite symposium held at Heart Rhythm 2015, Stroke Prevention in Atrial Fibrillation: Advancements in LAA Closure and Novel Oral Anticoagulation Therapy. Enjoy this web-based version of the symposium, which captures the live cases, lectures, debates, and interactive panel discussions from the symposium in HD video.
A New Horizon for the Management of Persistent AF through Hybrid Approaches
Review large unmet clinical need and challenges of treating persistent AF with current ablation approaches. Evaluate the safety and efficacy of dual epicardial and endocardial ablation for treating persistent or longstanding persistent AF. Assess outcomes data and clinical experiences for comprehensive posterior left atrial ablation in persistent AF patients.
A Patient-Centered Approach to Atrial Fibrillation-Related Stroke
The goal of this activity is to educate clinicians on the current pharmacologic stroke prevention strategies for patients with AF. This program is intended for cardiologists, primary care physicians, internists, neurologists, and allied healthcare professionals who manage patients with atrial fibrillation (AF).
AF Revalidation tool for GPs
This Atrial Fibrillation Revalidation Tool for UK GP’s also serves as an effective review and update for the Staff of EP Labs to have a broader understanding of their patients. Several videos on a variety of AF treatments, research and other topics.
Antiarrhythmics for Atrial Fibrillation: Practical Implications of Latest Clinical Developments
The goal of this activity is to apply recent findings from clinical trials to clinical practice by updating and acknowledging changes to guideline recommendations for the management of atrial fibrillation. This activity is intended for electrophysiologists, cardiologists, primary care physicians, and other healthcare providers involved in the treatment and care of patients with atrial fibrillation.
Arrhythmia & EP- The Heart.org
Up-to-date list of articles related to Atrial Fibrillation, and EP. The Heart.org. CME’s.
Arrhythmia Detection: Office Management in an Age of Advanced Technology
The goal of this activity is to provide practical strategies on effectively utilizing implantable cardiac arrhythmia monitors.
Atrial Fibrillation and Silent Cerebral Ischemia (JACC)
At the conclusion of this activity, the learner should be able to compare the prevalence of silent cerebral ischemia and cognitive performance in paroxysmal and persistent atrial fibrillation patients and controls in sinus rhythm.
Atrial Fibrillation Begets Heart Failure and Vice Versa
How is the development of atrial fibrillation (AF) temporally related to heart failure (HF)?
Atrial Fibrillation Info Site
Multiple presentations in video and text that study all facets of Atrial Fibrillation and its treatment. Excellent background information. Medscape.
Balancing Safety and Efficacy in Appropriately Selected AF Patients
The goal of this activity is to provide clinicians involved in the management of patients with atrial fibrillation with the knowledge necessary to implement new therapeutic paradigms into their clinical practices.
Basic Mechanisms of Cardiac Impulse Propagation and Associated Arrhythmias
The most detailed information on the subject I have seen. Text with numerous diagrams and illustrations. American physiological Society.
Case Studies in Atrial Fibrillation: Removing the Ambiguity Around Antiarrhythmic Drugs
This activity is intended for electrophysiologists, cardiologists, primary care physicians, and other healthcare providers involved in the treatment and care of patients with atrial fibrillation (AF). The goal of this activity is to apply recommendations from recent guideline updates for the management of atrial fibrillation to real-life cases.
Clinical Correlates and Clinical Controversies in Atrial Fibrillation: Has the Balance Shifted?
This activity thus focuses on the questions of whether, when, and why controlling rate or controlling rhythm is the preferred strategy in AF, and, in cases when rhythm control is indeed the preferred strategy, how it is best effected.
Clinical Crossroads in Thrombosis: Stroke Prevention in AF; Secondary Prevention in ACS
This program will evaluate available guidelines and emerging clinical trial data in this landscape in order to help physicians choose appropriate anticoagulation for the prevention of AF-related stroke, to address residual risk in the secondary prevention of ACS, and to manage patients with the overlapping syndromes of AF and ACS.
Clinician Survey: Managing Stroke Risk in Patients With Atrial Fibrillation
The goal of this activity is to evaluate knowledge of strategies to reduce the risk for stroke in patients who have atrial fibrillation and who may also have an acute coronary syndrome or history of stroke.
Driving Clinical and Financial Quality in Electrophysiology: A Step-by Step Approach to A-Fib Care
The latest statistics reveal that about one in four Americans over the age of 40 are at risk to develop atrial fibrillation (A-Fib), considered the most common type of arrhythmia treated today.
EP ConsultService: Challenging Cases in Management of Atrial Fibrillation
Upon completion of this activity, participants should be able to: 1.Outline an individual management strategy for AF patient cases based on AF features, presentation, and guideline recommendations. 2.Discuss how novel and emerging antiarrhythmic therapies can best be integrated into practice to reduce AF-related morbidity and mortality. 3.Cite evidence on which to base an AF management strategy which considers heart rate control as well as rhythm control.
Genetic Discoveries in Atrial Fibrillation and Implications for Clinical Practice
Atrial fibrillation (AF) is an arrhythmia with a genetic basis. Over the past decade, rapid advances in genotyping technology have revolutionized research regarding the genetic basis of AF.
How to Protect Your Patient From a Stroke: Achieving Positive Outcomes in AF
Despite the advent of novel oral anticoagulants, many patients with AF at risk for stroke remain undertreated or inadequately treated with aspirin. The goal of this activity is to provide strategies to identify patients with AF at risk for stroke and improve treatment rates and patient outcomes.
Innovative Approaches to Stroke Prevention in Atrial Fibrillation
Visit the diverse topic of stroke prevention in atrial fibrillation (AF), a concept that continues to evolve with both mechanical and pharmacological innovation. In order to demonstrate the different treatment options for these patients, this issue offers a series of manuscripts from respected colleagues from the field, along with a commentary by our Innovative Techniques Section Editor, Samuel Asirvatham. There are many new left atrial appendage closure (LAAC) options for stroke prevention in AF, and the content within this issue should help to outline these new and innovative approaches.
Is Atrial Fibrillation Necessary? The Most Important Study Presented at the Heart Rhythm Society 2014 Scientific Sessions
Registration necessary. What follows is a report on what may be (pardon the big word) an inflection point in the way we think about the most common heart-rhythm disorder.
LAA Closure for Atrial Fibrilation using Occlusion Device
Atrial Fibrilation Female, 87 years Clinical Symptoms: Palpitations, Dyspnea on excertion Concomitant Diseases: Hypertension Hypothyreosis Iron deficiency anemia of unknown cause Implanted Device: Watchman, Boston Scientific
Management of AF patients with ACS
The optimal regimen for AF patients requiring a coronary stent is unclear and the video will discuss the combination risk of oral anticoagulants and aspirin.
Managing Side Effects in Newly Diagnosed Atrial Fibrillation
This activity is intended for cardiologists, electrophysiologists, primary care practitioners, and allied healthcare providers involved in the diagnosis and treatment of patients with atrial fibrillation (AF). The goal of this activity is to identify comorbidities and patient-specific characteristics that influence prognosis and treatment strategies in AF and apply guideline recommendations to improve outcomes in patients with AF
Mechanical Approaches to Stroke Prevention in Atrial Arrhythmias
Stroke is a common and perhaps the most feared complication of atrial fibrillation (AF) and other atrial tachyarrhythmias. The prevention of cerebrovascular and other thromboembolic events is one of the most important goals of AF therapy.
Of Ends and Means: Toward Optimized Outcomes in Atrial Fibrillation
This activity focuses on the question of whether or when controlling rate or controlling rhythm is the preferred strategy in atrial fibrillation (AF), and, in cases when rhythm control is indeed the preferred strategy, how it should be effected.
Patient-Centric Care in Atrial Fibrillation: Addressing Fears and Improving Quality of Life
The goal of this activity is to provide a review of the morbidity and mortality of atrial fibrillation-related stroke and the need for effective prophylaxis.
Percutaneous Left Atrial Appendage Closure using the Watchman Device
Percutaneous Left Atrial Appendage Closure using the Watchman Device by Dr. Vivek Reddy, Professor of Cardiology, Mount Sinai Hospital, New York, NY.
Perspectives on Asian Patients With Atrial Fibrillation
Evaluate the management of stroke prevention in Japan, including factors to consider to improve patient outcomes Determine safety considerations for NOACs based on meta-analyses and postmarketing surveillance.
Preventing AF-Related Stroke in a Patient With Previous Myocardial Infarction
The goal of this program is to explore new treatment paradigms to address the challenges of managing patients with atrial fibrillation who have had a previous myocardial infarction and who have coronary artery disease.
Realizing the Burden of AF: A Hard Look at Quality of Life and Hospitalizations
The goal of this activity is to update physicians & staff’s knowledge about AF management strategies and their impact on patient outcomes and patient quality of life.
Rhythm Control: What Therapy for What Patient?
This 30-minute webcast covers the spectrum of rhythm control strategies with focused topics, including the recent update to the Atrial Fibrillation Guidelines, pharmacological treatment options, and the latest thinking on rate vs. rhythm control.
Safety of Left Atrial Appendage Closure With WATCHMAN Device
What are the procedural success and complications, and long-term patient outcomes, including bleeding and incidence of stroke/transient ischemic attack (TIA), with the WATCHMAN device? – See more at: http://www.acc.org/latest-in-cardiology/journal-scans/2016/02/02/16/04/implant-success-and-safety-of-left-atrial-appendage-closure?WT.mc_ev=EmailOpen&w_pub=JScan160211&w_nav=JScan#sthash.lwbuc51Z.dpuf
Strategies and Clinical Insights to Reduce Stroke Risk in Atrial Fibrillation
This activity is based on the slides and lectures presented by the faculty at the symposium, Strategies to Reduce Stroke Risk in Atrial Fibrillation: You Be the Judge!, on November 14, 2011, at The Peabody Orlando, Orlando, Florida.
Stroke of Unknown Cause CME. Valid for credit through 03/26/2016
The goal of this activity is to provide clinical guidance on the diagnosis and management of arrhythmias in patients with cryptogenic stroke.
Surgery for Atrial Fibrillation
What is available outside the EP Lab for your patients. Be knowledgeable about other treatments for your patients. New surgical techniques are bringing surgical treatment of atrial fibrillation back into the spotlight. The current review describes these techniques and their efficacy. Text. Medscape. CME’s. Free registration.
The Burdens of AF-Related Stroke: Concepts in Managing Economic and Human Costs
The goal of this activity is to provide an update on the cost-effectiveness of novel oral anticoagulants in treating patients with atrial fibrillation who are risk for, or who have already had a stroke.
The Role of Genotyping for Risk-Stratifying Patients at Risk for Atrial Fibrillation and Stroke
This activity is intended for general cardiologists, interventional cardiologists, electrophysiologists, and primary care physicians involved in the care of patients with or at risk for atrial fibrillation. The goal of this activity is to discuss the role of genetic testing in assessing risk for atrial fibrillation and stroke.
Triple Trouble: AF, Renal Dysfunction and Elderly
Identify patient types with atrial fibrillation (AF) at risk for stroke: elderly patients with renal dysfunction Determine pharmacokinetic characteristics of OACs that affect selection of agent and dosing considerations.
When the Cause of Stroke Is Not Crystal Clear
The goals of this activity are to review the challenges in diagnosing cryptogenic stroke and to highlight recent clinical trial data for identifying silent atrial fibrillation.
Which Therapeutic Options for AF Patients, for Whom, and Why?
The goal of this activity is to illustrate with cases how the presentation and stages of atrial fibrillation can influence therapeutic strategies. This activity is intended for electrophysiologists, cardiologists, primary care physicians, and other healthcare providers involved in the treatment and care of patients with atrial fibrillation (AF).
